| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/02/2004 | US20040242527 System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 12/02/2004 | US20040242526 Disruption of the REG pathway |
| 12/02/2004 | US20040242525 Method for promoting gonadal growth in an animal |
| 12/02/2004 | US20040242523 Combination chemotherapy using a tumor necrosis factor-alpha expression construct and doxorubicin, cyclophosphamide, 5-fluorouracil, taxol or gemcitabine; lower dosages, decreased toxicity |
| 12/02/2004 | US20040242522 Polynucleotide vaccine formulations |
| 12/02/2004 | US20040242520 Expression of immonogenic substances |
| 12/02/2004 | US20040242516 Antisense modulation of apolipoprotein(a) expression |
| 12/02/2004 | US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis |
| 12/02/2004 | US20040242514 Xenogenic oligo or/and polyribonucleotides as agents for the treatment of malignant tumours |
| 12/02/2004 | US20040242513 Tub antisense constructs |
| 12/02/2004 | US20040242510 Methods and compositions for detecting colon cancers |
| 12/02/2004 | US20040242487 Identifying a subject in need of inhibiting appetite or weight gain and administering an effective amount of an antagonist of melanocyte concentrating hormone (MCH) to subject, wherein antagonist binds an MCH receptor |
| 12/02/2004 | US20040242481 Use of hmgb1 for the activation of dendritic cells |
| 12/02/2004 | US20040242461 Modulators of telomere stability |
| 12/02/2004 | US20040242416 Compositions and methods for intracellular delivery |
| 12/02/2004 | US20040241857 Tissue specific adenoviral vectors |
| 12/02/2004 | US20040241855 Polyoxyethylene glycol (peg)-lipid-immunogen conjugates; for incorporation into liposomes to enhance intracelllar delivery of nucleic acids and drugs |
| 12/02/2004 | US20040241854 Mammalian cells comprising rna sequences directed towards gene which codes transcript for swedish double amyloid precursor protein mutation or a transcript for tau gene product for use in posttranscriptional gene silencing and treatment of alzheimer's disease; gene therapy |
| 12/02/2004 | US20040241844 Oligonucleotides for controlling expression of c-reactive protein for use in treatment of infection, autoimmune, diabetic or inflammatory disease |
| 12/02/2004 | US20040241826 Mycobacterial antigens expressed during latency |
| 12/02/2004 | US20040241821 Replication competent yellow fever virus for propagation of immunoglobulin conjugate for use in detection tumor associated antigen expression and treatment of cell proliferative disorders in mammals; cancer diagnosis; immunotherapy |
| 12/02/2004 | US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241796 Kinase for use as tool in identification of modulators for treatment and prevention of diabetic, cell prolliferative, cardiovascular and respiratory system disorders |
| 12/02/2004 | US20040241706 Such as 2-amino-6-O-(2',2'-dimethyl)propyl-9-N-benzylpurine with modified guanosine triphosphate groups, which affects activity of mutant strains rather than wild-type strains; enzyme inhibitors; host cells; solid phase synthesis |
| 12/02/2004 | US20040241682 Cancer |
| 12/02/2004 | US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines |
| 12/02/2004 | US20040241181 Preferentially inducing a more potent CD8+ T cell response to an immunogen by delivering a recombinant simian adenovirus comprising a nucleic acid molecule encoding an immunogen under the control of gene expression regulatory sequences directing expression of the immunogen; HIV; rabies; papilloma virus |
| 12/02/2004 | US20040241177 Novel compositions and uses therefor |
| 12/02/2004 | US20040241166 Use of inhibitors of ikk-beta and method for discovery of said inhibitors |
| 12/02/2004 | US20040241163 Secreted human cytomegalovirus protein or fragment thereof binds rantes chemokine; for treating chemokine-associated inflammatory or immune pathological conditions such as transplant rejection, arteriosclerosis, rheumatoid arthritis, asthma, endometriosis, and cancer |
| 12/02/2004 | US20040241148 skin components having three dimensional structure of the tissue from which they are derived, and having dimensions so as to allow diffusion of nutrients, gases and wastes to and from cells |
| 12/02/2004 | US20040241141 gene delivery using retroviral genetic vectors such that the gene is expressed at sufficient levels and for a sufficient time for prophylaxis of rheumatic diseases in humans or mammals |
| 12/02/2004 | US20040241139 viral genes in covalent junction with foreign, genetically engineered genes; ribonucleic acid segments having upstream splicing donors and downstream splicing acceptor signal surrounding the proximal coding regions; vaccines |
| 12/02/2004 | US20040241088 Method for evaluating the efficacy of certain cancer treatments |
| 12/02/2004 | CA2528521A1 Disease prevention and vaccination prior to thymic reactivations |
| 12/02/2004 | CA2526212A1 Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 12/02/2004 | CA2525304A1 Recombinant gene medicine of adenovirus vector and gene p53 for treating proliferative diseases |
| 12/02/2004 | CA2525181A1 Tnf-like secreted protein |
| 12/02/2004 | CA2431080A1 Enhancement of anticancer immunity through inhibition of arginase |
| 12/01/2004 | EP1482042A1 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor |
| 12/01/2004 | EP1482037A1 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering RNA precursors enabling the formation of small interfering RNA in vivo and in vitro |
| 12/01/2004 | EP1481989A1 A-33 related antigens and their pharmacological uses |
| 12/01/2004 | EP1481095A2 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 12/01/2004 | EP1481067A1 Expression cassette for persistence of expression of a gene of interest in muscle cells |
| 12/01/2004 | EP1481054A2 Il-10 gene transfer to peripheral mononuclear cells |
| 12/01/2004 | EP1481009A2 Peptides for use in antitumor immunotherapy |
| 12/01/2004 | EP1480995A2 Cks1 INHIBITORS |
| 12/01/2004 | EP1480674A1 Treatment of central nervous system damage |
| 12/01/2004 | EP1480671A2 Recombinant rsv virus expression systems and vaccines |
| 12/01/2004 | EP1480670A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis |
| 12/01/2004 | EP1480669A1 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage |
| 12/01/2004 | EP1480668A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization,or both, in humans |
| 12/01/2004 | EP1480656A1 Hyaluronic acid mediated adenoviral transduction |
| 12/01/2004 | EP1480621A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 12/01/2004 | EP1480598A2 Manipulation of cytokine levels using cd83 gene products |
| 12/01/2004 | EP1439861A4 Methods and kits for use in selecting approaches to treating cancer |
| 12/01/2004 | EP1379139A4 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 12/01/2004 | EP1212428B1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 12/01/2004 | EP1189631B1 Neurodegenerative disorder related gene |
| 12/01/2004 | EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway |
| 12/01/2004 | EP1121449A4 Delivery system for porcine somatotropin |
| 12/01/2004 | EP0551401B2 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| 12/01/2004 | CN1551783A Method for treating multiple myeloma |
| 12/01/2004 | CN1551782A Chimeric flavivirus vectors |
| 12/01/2004 | CN1551781A One dose vaccination with mycoplasma hyopneumoniae |
| 12/01/2004 | CN1551728A Production of transduced hematopoietic progenitor cells |
| 12/01/2004 | CN1550550A Oncogene, recombinant protein derived therefrom, and uses thereof |
| 12/01/2004 | CN1177934C Adneovirus-mediated intratumoral delivery of angiogenesis antagonist for treatment of tumors |
| 12/01/2004 | CN1177863C Attenuated microorganisms for treatment of infection |
| 12/01/2004 | CN1177616C Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof |
| 12/01/2004 | CN1177615C Arteriovenous and venous graft treatment methods and compsns. |
| 12/01/2004 | CN1177610C Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 11/30/2004 | US6825920 Method and system of determining chamber seasoning condition by optical emission |
| 11/30/2004 | US6825329 Human PEM as a target for birth control and treatment of Alzheimer's disease |
| 11/30/2004 | US6825035 For drug screening; gene knockout; genetic engineering |
| 11/30/2004 | US6825033 Mutated cyclin G1 protein |
| 11/30/2004 | US6825028 For expressing foreign proteins in cells/tissue/organ/body; somatic gene therapy |
| 11/30/2004 | US6825008 Expressed ligand—vascular intercellular signalling molecule |
| 11/30/2004 | US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids |
| 11/30/2004 | US6824991 Human bad polypeptides, encoding nucleic acids and methods of use |
| 11/30/2004 | US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 11/30/2004 | US6824976 Method for selective inactivation of viral replication |
| 11/30/2004 | US6824973 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders |
| 11/30/2004 | US6824773 TWEAK receptor |
| 11/30/2004 | US6824771 Increased coxsackle-adenovirus receptor (car) expression on tumor cells; modification of viral tropism enhancing tumor transduction and selectivity |
| 11/30/2004 | US6824767 Nuclelotide sequences coding polypeptide for use in the treatment of tumors, cachexia, septic shock, brain disorders, inflammation, arthritis and immunological defects |
| 11/30/2004 | US6824561 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 11/30/2004 | CA2468118A1 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering rna precursors enabling the formation and function of small interfering rna in vivo and in vitro |
| 11/25/2004 | WO2004102195A1 Method for identifying tff2 regulating agents and agents identified using said method |
| 11/25/2004 | WO2004101801A2 Improved method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding generic tools, as well as the applications of these non-pathogenic amplicons vectors |
| 11/25/2004 | WO2004101800A1 Dna constructs and vectors for the inducible expression of nucleotide sequences |
| 11/25/2004 | WO2004101799A2 Broadening adenovirus tropism |
| 11/25/2004 | WO2004101795A1 Variable proteins of mycoplasma mycoides, vaccines and process thereof |
| 11/25/2004 | WO2004101777A1 A recombinant virus comprising an intact tumor-therapeutic antibody with human costant regions and the use thereof |
| 11/25/2004 | WO2004101766A2 Grp94-based compositions and methods of use thereof |
| 11/25/2004 | WO2004101764A2 Methods of modulating metastasis and skeletal related events resulting from metastases |
| 11/25/2004 | WO2004101745A2 NOVEL REGULATORY MECHANISMS OF NF-kappaB |
| 11/25/2004 | WO2004100977A1 Inhibition of tumor cell proliferation by foxm1b inhibitors |
| 11/25/2004 | WO2004100877A2 Vaccine accelerator factor (vaf) for poultry |